In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.

Al Jalali, Valentin; Sauermann, Robert; Eberl, Sabine; Zeitlinger, Markus

Al Jalali, Valentin; Sauermann, Robert; Eberl, Sabine; Zeitlinger, Markus.

Afiliação

Al Jalali V; Department of Clinical Pharmacology, Vienna University Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Sauermann R; Department of Clinical Pharmacology, Vienna University Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Eberl S; Department of Clinical Pharmacology, Vienna University Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Zeitlinger M; Department of Clinical Pharmacology, Vienna University Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.

Infection ; 47(4): 565-570, 2019 Aug.

Article em En | MEDLINE | ID: mdl-30725316

Assuntos

Anfotericina B/farmacologia; Antifúngicos/farmacologia; Candida/efeitos dos fármacos; Líquido Cefalorraquidiano/microbiologia; Cryptococcus neoformans/efeitos dos fármacos; Voriconazol/farmacologia; Candida albicans/efeitos dos fármacos; Candidíase/líquido cefalorraquidiano; Infecções do Sistema Nervoso Central/líquido cefalorraquidiano; Criptococose/líquido cefalorraquidiano; Humanos

Palavras-chave

Antifungal activity; Antifungal agents; Fungal infections; Meningitis; PK/PD

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida / Líquido Cefalorraquidiano / Anfotericina B / Cryptococcus neoformans / Voriconazol / Antifúngicos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google